Form 4 for RVTY Revvity
Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-07 · accession 0000950170-25-003432 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-01-08 | 2025-01-07 | RVTY | Vohra Tajinder S | Please See Remarks | S - Sale+OE | $116.81 | -5,492 | 19.9K | -22% | -$641.5K |
| DT | 2025-01-08 | 2025-01-07 | RVTY | Vohra Tajinder S | Please See Remarks | M - OptEx | $81.29 | +5,492 | 25.1K | +28% | +$446.4K |
| DT | 2025-01-08 | 2025-01-07 | RVTY | Vohra Tajinder S | Please See Remarks | M - OptEx | $0.00 | +5,492 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-07 | S | D | 200 | $118.92 | 19,652 | D | — | — | (F6) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $118.84 to $119.00. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-01-07 | S | D | 2,388 | $117.14 | 20,326 | D | — | — | (F4) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.69 to $117.60. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-01-07 | S | D | 2,430 | $116.13 | 22,714 | D | — | — | (F3) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.62 to $116.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-01-07 | M | A | 5,492 | $81.29 | 25,144 | D | — | — | (F1) The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error. |
| 5 | Common | Common Stock | 2025-01-07 | S | D | 474 | $117.79 | 19,852 | D | — | — | (F5) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $117.71 to $117.88. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | NQ Stock Option (right to buy) | 2025-01-07 | M | A | 5,492 | $0.00 | 0 | D | $81.29 · — to 2025-01-30 | 5,492 Common Stock | (F7) This option became exercisable in three equal annual installments beginning on January 30, 2019, which was the first anniversary of the date on which the option was granted. |